BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34623817)

  • 1. The Discovery and Biosynthesis of Nicotinic Myxochelins from an
    Wang DG; Niu L; Lin ZM; Wang JJ; Gao DF; Sui HY; Li YZ; Wu C
    J Nat Prod; 2021 Oct; 84(10):2744-2748. PubMed ID: 34623817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the Myxochelin Natural Product Family by Nicotinic Acid Containing Congeners.
    Frank NA; Széles M; Akone SH; Rasheed S; Hüttel S; Frewert S; Hamed MM; Herrmann J; Schuler SMM; Hirsch AKH; Müller R
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel insights into siderophore formation in myxobacteria.
    Gaitatzis N; Kunze B; Müller R
    Chembiochem; 2005 Feb; 6(2):365-74. PubMed ID: 15678426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery, Biosynthesis and Biological Activity of a Succinylated Myxochelin from the Myxobacterial Strain MSr12020.
    Okoth DA; Hug JJ; Garcia R; Müller R
    Microorganisms; 2022 Sep; 10(10):. PubMed ID: 36296235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering Pseudochelin Production in Myxococcus xanthus.
    Korp J; Winand L; Sester A; Nett M
    Appl Environ Microbiol; 2018 Nov; 84(22):. PubMed ID: 30217842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myxochelins target human 5-lipoxygenase.
    Schieferdecker S; König S; Koeberle A; Dahse HM; Werz O; Nett M
    J Nat Prod; 2015 Feb; 78(2):335-8. PubMed ID: 25686392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing Enzymatic Promiscuity in Myxochelin Biosynthesis for the Production of 5-Lipoxygenase Inhibitors.
    Korp J; König S; Schieferdecker S; Dahse HM; König GM; Werz O; Nett M
    Chembiochem; 2015 Nov; 16(17):2445-50. PubMed ID: 26416255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro reconstitution of the myxochelin biosynthetic machinery of Stigmatella aurantiaca Sg a15: Biochemical characterization of a reductive release mechanism from nonribosomal peptide synthetases.
    Gaitatzis N; Kunze B; Müller R
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11136-41. PubMed ID: 11562468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myxochelin biosynthesis: direct evidence for two- and four-electron reduction of a carrier protein-bound thioester.
    Li Y; Weissman KJ; Müller R
    J Am Chem Soc; 2008 Jun; 130(24):7554-5. PubMed ID: 18498160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhypyrazinones A and B, Pyrazinone Natural Products from a Marine-Derived Myxobacterium
    Zhang F; Braun DR; Rajski SR; DeMaria D; Bugni TS
    Mar Drugs; 2019 Dec; 17(12):. PubMed ID: 31842310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in discovery and biosynthesis of natural products from myxobacteria: an overview from 2017 to 2023.
    Wang CY; Hu JQ; Wang DG; Li YZ; Wu C
    Nat Prod Rep; 2024 Jun; 41(6):905-934. PubMed ID: 38390645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Constitutive Promoters for the Elicitation of Secondary Metabolites in Myxobacteria.
    Hu WF; Niu L; Yue XJ; Zhu LL; Hu W; Li YZ; Wu C
    ACS Synth Biol; 2021 Nov; 10(11):2904-2909. PubMed ID: 34757714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The myxochelin iron transport regulon of the myxobacterium Stigmatella aurantiaca Sg a15.
    Silakowski B; Kunze B; Nordsiek G; Blöcker H; Höfle G; Müller R
    Eur J Biochem; 2000 Nov; 267(21):6476-85. PubMed ID: 11029592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthesis and Total Synthesis of Pyrronazol B: a Secondary Metabolite from Nannocystis pusilla.
    Witte SNR; Hug JJ; Géraldy MNE; Müller R; Kalesse M
    Chemistry; 2017 Nov; 23(63):15917-15921. PubMed ID: 28944573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsclerodermins from terrestrial myxobacteria: an intriguing biosynthesis likely connected to a sponge symbiont.
    Hoffmann T; Müller S; Nadmid S; Garcia R; Müller R
    J Am Chem Soc; 2013 Nov; 135(45):16904-11. PubMed ID: 24124771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal organization of biosynthetic gene clusters suggests plasticity of myxobacterial specialized metabolism including descriptions for nine novel species:
    Ahearne A; Phillips K; Knehans T; Hoing M; Dowd SE; Stevens DC
    bioRxiv; 2023 Mar; ():. PubMed ID: 36945379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myxobacterial natural product assembly lines: fascinating examples of curious biochemistry.
    Wenzel SC; Müller R
    Nat Prod Rep; 2007 Dec; 24(6):1211-24. PubMed ID: 18033576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and biosynthesis of sorangipyranone - a new γ-dihydropyrone from the myxobacterial strain MSr12020.
    Okoth DA; Hug JJ; Mándi A; Kurtán T; Garcia R; Müller R
    J Ind Microbiol Biotechnol; 2021 Jun; 48(3-4):. PubMed ID: 34003283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis of phenylnannolone A, a multidrug resistance reversal agent from the halotolerant myxobacterium Nannocystis pusilla B150.
    Bouhired SM; Crüsemann M; Almeida C; Weber T; Piel J; Schäberle TF; König GM
    Chembiochem; 2014 Mar; 15(5):757-65. PubMed ID: 24677362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural products from myxobacteria: novel metabolites and bioactivities.
    Herrmann J; Fayad AA; Müller R
    Nat Prod Rep; 2017 Feb; 34(2):135-160. PubMed ID: 27907217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.